He is also a co-director of the Integrative Neuroscience Graduate Program at the University and a director of the National ...

Brett Favre was diagnosed with Parkinson's disease in January after he began having trouble using his right arm and was ...

The panel agreed with the FDA that the treatment in which a patient's tissue is processed doesn't fall under the same ...

Leerink Partners analyst David Risinger has maintained their neutral stance on ABBV stock, giving a Hold rating on September 13. David ...

On Tuesday, former NFL quarterback Brett Favre revealed he has Parkinson's disease. Favre said five specialists told him they ...

SIOUX FALLS S.D. (KELO) –Former Green Bay Packers quarterback Brett Favre recently announced that he has been diagnosed with ...

There we were, Loren and I, sitting on the old, cozy couch set in the sandy parking lot outside Angel Foods in Provincetown.

Discover the potential of GLP-1 medications like Ozempic and Mounjaro in treating a wide range of conditions, from diabetes to addiction.

Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational ...

The phase 3 Tempo-1 trial for tavapadon, a dopamine receptor partial agonist, demonstrated significant efficacy as a monotherapy in early Parkinson's disease. Patients receiving the drug at doses of 5 ...

The Phase III TEMPO-1 trial enrolled 529 adults aged between 40 and 80 years, diagnosed with Parkinson’s for less than three ...